Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-23-041

The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.
Categories: Education, Health.

More Information

Visit Website

Posted on

Application Deadline

Type

Research/project funding

Reference Number

PAR-23-041

United States